journavx pain management - Search News

FDA approves new pain medication

USA TODAY on MSN · 1h

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Newsweek on MSN · 16h

What Is Journavx? First Pain Medication Approved by FDA in Over Two Decades

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

Medscape · 50m

FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective relief of acute pain without the risk of addiction.

2h

FDA approves new medication as alternative to opioids for pain treatment

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results